Cargando…

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques

The tuberculosis vaccine, Bacille Calmette-Guerin (BCG), also affords protection against non-tuberculous diseases attributable to heterologous immune mechanisms such as trained innate immunity, activation of non-conventional T-cells, and cross-reactive adaptive immunity. Aerosol vaccine delivery can...

Descripción completa

Detalles Bibliográficos
Autores principales:	White, Andrew D., Sibley, Laura, Sarfas, Charlotte, Morrison, Alexandra L., Bewley, Kevin, Churchward, Colin, Fotheringham, Susan, Gkolfinos, Konstantinos, Gooch, Karen, Handley, Alastair, Humphries, Holly E., Hunter, Laura, Kennard, Chelsea, Longet, Stephanie, Mabbutt, Adam, Moffatt, Miriam, Rayner, Emma, Tipton, Tom, Watson, Robert, Hall, Yper, Bodman-Smith, Mark, Gleeson, Fergus, Dennis, Mike, Salguero, Francisco J., Carroll, Miles, McShane, Helen, Cookson, William, Hopkin, Julian, Sharpe, Sally
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863871/ https://www.ncbi.nlm.nih.gov/pubmed/35222355 http://dx.doi.org/10.3389/fimmu.2021.801799

Ejemplares similares

IV BCG Vaccination and Aerosol BCG Revaccination Induce Mycobacteria-Responsive γδ T Cells Associated with Protective Efficacy against M. tb Challenge
por: Morrison, Alexandra L., et al.
Publicado: (2023)

One or two dose regimen of the SARS-CoV-2 synthetic DNA vaccine INO-4800 protects against respiratory tract disease burden in nonhuman primate challenge model
por: Gooch, Karen E., et al.
Publicado: (2021)

Immunological and pathological outcomes of SARS-CoV-2 challenge following formalin-inactivated vaccine in ferrets and rhesus macaques
por: Bewley, Kevin R., et al.
Publicado: (2021)

Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol M. tuberculosis Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2020)

TB and SIV Coinfection; a Model for Evaluating Vaccine Strategies against TB Reactivation in Asian Origin Cynomolgus Macaques: A Pilot Study Using BCG Vaccination
por: White, Andrew D., et al.
Publicado: (2021)

Alternative BCG delivery strategies improve protection against Mycobacterium tuberculosis in non-human primates: Protection associated with mycobacterial antigen-specific CD4 effector memory T-cell populations
por: Sharpe, S., et al.
Publicado: (2016)

Bacillus Calmette-Guerin (BCG) induces superior anti-tumour responses by Vδ2(+) T cells compared with the aminobisphosphonate drug zoledronic acid
por: Fenn, J, et al.
Publicado: (2022)

SARS-CoV-2 Disease Severity in the Golden Syrian Hamster Model of Infection Is Related to the Volume of Intranasal Inoculum
por: Handley, Alastair, et al.
Publicado: (2023)

High-dose Mycobacterium tuberculosis aerosol challenge cannot overcome BCG-induced protection in Chinese origin cynomolgus macaques; implications of natural resistance for vaccine evaluation
por: Sibley, Laura, et al.
Publicado: (2021)

Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines
por: Harris, Stephanie A., et al.
Publicado: (2018)

Evaluation of the Immunogenicity of Mycobacterium bovis BCG Delivered by Aerosol to the Lungs of Macaques
por: White, A. D., et al.
Publicado: (2015)

Characterization of the Infant Immune System and the Influence and Immunogenicity of BCG Vaccination in Infant and Adult Rhesus Macaques
por: Sarfas, Charlotte, et al.
Publicado: (2021)

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
por: White, Andrew D., et al.
Publicado: (2023)

Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19
por: Salguero, Francisco J., et al.
Publicado: (2021)

Cheap and Commonplace: Making the Case for BCG and γδ T Cells in COVID-19
por: Morrison, Alexandra L., et al.
Publicado: (2021)

Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods
por: Rhodes, Sophie J., et al.
Publicado: (2017)

Differences in host immune populations between rhesus macaques and cynomolgus macaque subspecies in relation to susceptibility to Mycobacterium tuberculosis infection
por: Sibley, Laura, et al.
Publicado: (2021)

MTBVAC vaccination protects rhesus macaques against aerosol challenge with M. tuberculosis and induces immune signatures analogous to those observed in clinical studies
por: White, Andrew D., et al.
Publicado: (2021)

ChAdOx1 nCoV-19 protection against SARS-CoV-2 in rhesus macaque and ferret challenge models
por: Lambe, Teresa, et al.
Publicado: (2021)

Editorial Commentary: Understanding BCG Is the Key to Improving It
por: McShane, Helen
Publicado: (2014)

Development of a Hamster Natural Transmission Model of SARS-CoV-2 Infection
por: Dowall, Stuart, et al.
Publicado: (2021)

The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019)

Molecular assessment of mycobacterial burden in the treatment of nontuberculous mycobacterial disease
por: Ellis, Huw C., et al.
Publicado: (2023)

Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in Cattle
por: Dean, Gillian S., et al.
Publicado: (2015)

Syrian hamster convalescence from prototype SARS-CoV-2 confers measurable protection against the attenuated disease caused by the Omicron variant
por: Ryan, Kathryn A., et al.
Publicado: (2023)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
por: Villarreal-Ramos, Bernardo, et al.
Publicado: (2014)

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of Mycobacterium tuberculosis Infection
por: Sibley, Laura, et al.
Publicado: (2022)

The Omicron Sub-Variant BA.4 Displays a Remarkable Lack of Clinical Signs in a Golden Syrian Hamster Model of SARS-CoV-2 Infection
por: Davies, Elizabeth R., et al.
Publicado: (2023)

Dose-Dependent Response to Infection with Ebola Virus in the Ferret Model and Evidence of Viral Evolution in the Eye
por: Watson, Robert J., et al.
Publicado: (2021)

Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2009)

Comparative pathology of VIC01 isolate and Omicron variant of SARS-CoV-2 infection, including a rechallenge model, in the Golden Syrian hamster
por: Rayner, E., et al.
Publicado: (2023)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A
por: Whelan, Kathryn T., et al.
Publicado: (2011)

Characterisation of the T-cell response to Ebola virus glycoprotein amongst survivors of the 2013–16 West Africa epidemic
por: Tipton, T. R. W., et al.
Publicado: (2021)

Evaluation of a Human BCG Challenge Model to Assess Antimycobacterial Immunity Induced by BCG and a Candidate Tuberculosis Vaccine, MVA85A, Alone and in Combination
por: Harris, Stephanie A., et al.
Publicado: (2014)

Preclinical Development of an In Vivo BCG Challenge Model for Testing Candidate TB Vaccine Efficacy
por: Minassian, Angela M., et al.
Publicado: (2011)

An aerosol challenge model of tuberculosis in Mauritian cynomolgus macaques
por: Sharpe, S. A., et al.
Publicado: (2017)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis()
por: Poyntz, Hazel C., et al.
Publicado: (2014)

BCG: Disseminated BCG infection: case report
Publicado: (2022)

Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity
por: Ryan, Kathryn A., et al.
Publicado: (2021)

Induction of Functional Specific Antibodies, IgG-Secreting Plasmablasts and Memory B Cells Following BCG Vaccination
por: Bitencourt, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6bgln6jqo5m0l6692u2hlg82hn